GLP Watchdog

Hers vs PlushCare

Hers has an open FDA warning letter dated September 9, 2025. PlushCare has none. On compounded semaglutide injection, PlushCare costs $600 less a year at standing rates: $149 a month against $199 a month at Hers.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Hers / PlushCare

Hers logo

Hers

6.8/10

PlushCare logo

PlushCare

6.4/10

FDA warning letters
None on record
Pharmacy
None named in our record
Lowest standing price
$199/moCompounded semaglutide injection
$149/moCompounded semaglutide injection
States
All 50 states
All 50 states
Checked
Prices captured Record checked September 2026
Prices captured Record checked September 2026
Visit Hers
Visit PlushCare

Neither Hers nor PlushCare pays us. Links to them earn nothing. Scores: Hers 6.8, PlushCare 6.4. How we are paid

What the record shows

  1. 01

    Hers has an open FDA warning letter dated September 9, 2025. PlushCare has none.

  2. 02

    Hers names three pharmacies. PlushCare names no compounding pharmacy in our record.

  3. 03

    On compounded semaglutide injection, PlushCare costs $600 less a year at standing rates: $149 a month against $199 a month at Hers.

  4. 04

    Only Hers lists a price for brand-name tirzepatide pen. Only PlushCare lists a price for compounded tirzepatide injection.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Hers

PlushCare

Compounded semaglutide injection

$199/mo

$2,388 a year

$149/moLower

$1,788 a year

Compounded tirzepatide injection
Not sold or not priced

$399/mo

$4,788 a year

Brand-name tirzepatide pen

$299/mo

medication only, membership extra; not compared

Not sold or not priced
Price includes
Medication
Not stated
Billed separately
Clinician visits, coaching
Medication, clinician visits, labs
Cancel any time
Yes, stated
Yes, stated
Minimum term
None
None; membership is billed monthly or annually
Refunds
No refund guaranteed once the pharmacy has processed an order
Appointment cost only; membership fees and prescriptions are not refunded

Read off each seller’s own pages. Hers: September 28, 2026. PlushCare: July 10, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Hers

6.8/10
  • Sells brand-name tirzepatide pen, which PlushCare does not price
  • Names its compounding pharmacy
  • Open FDA warning letter, September 9, 2025
  • Price leaves out clinician visits and coaching
Visit Hers

The case for PlushCare

6.4/10
  • No FDA warning letter on record
  • $600 a year less on compounded semaglutide injection
  • Sells compounded tirzepatide injection, which Hers does not price
  • Names no compounding pharmacy
  • Price leaves out medication, clinician visits and labs
Visit PlushCare

Scores

Hers 6.8 · PlushCare 6.4 out of 10. Six weighted parts.

Value25%

3.0A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
7.0

Trust & Safety15%

7.0A
vs
B
7.5

Accessibility10%

10.0A
vs
B
10.0

Support10%

3.0A
vs
B
0.0

The score is the same formula for every seller. Payment does not enter it. Method

Hers vs PlushCare: questions

Hers has an open FDA warning letter dated September 9, 2025. PlushCare has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Hers names three pharmacies. PlushCare names no compounding pharmacy in our record.
PlushCare, by $600 a year at standing rates. Hers: $199 a month, about $2,388 a year. PlushCare: $149 a month, about $1,788 a year.
Hers states you can cancel at any time; refunds: no refund guaranteed once the pharmacy has processed an order. PlushCare states you can cancel at any time; refunds: appointment cost only; membership fees and prescriptions are not refunded.
Neither Hers nor PlushCare pays us. Links to them earn nothing. Scores: Hers 6.8, PlushCare 6.4.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks